Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Seibert

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Medicinal Research Reviews|May 8, 1999
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)J J Talley, S R Bertenshaw, D L Brown, et al.
Nature|December 19, 1996
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsR G Kurumbail, A M Stevens, J K Gierse, et al.
Journal of Medicinal Chemistry|March 15, 2000
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2J J Talley, D L Brown, J S Carter, et al.
Journal of Medicinal Chemistry|April 26, 1996
Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, M B Norton, E J Reinhard, et al.
Journal of Cardiovascular Electrophysiology|November 18, 1997
Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncopeA Militianu, A Salacata, K Seibert, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agentsI K Khanna, R M Weier, Y Yu, et al.
Journal of Medicinal Chemistry|August 24, 2000
Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agentsI K Khanna, Y Yu, R M Huff, et al.
Journal of Medicinal Chemistry|January 5, 1996
Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipsH C Huang, J J Li, D J Garland, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Medicinal Research Reviews|May 8, 1999
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)J J Talley, S R Bertenshaw, D L Brown, et al.
Nature|December 19, 1996
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsR G Kurumbail, A M Stevens, J K Gierse, et al.
Journal of Medicinal Chemistry|March 15, 2000
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2J J Talley, D L Brown, J S Carter, et al.
Journal of Medicinal Chemistry|April 26, 1996
Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, M B Norton, E J Reinhard, et al.
Journal of Cardiovascular Electrophysiology|November 18, 1997
Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncopeA Militianu, A Salacata, K Seibert, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agentsI K Khanna, R M Weier, Y Yu, et al.
Journal of Medicinal Chemistry|August 24, 2000
Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agentsI K Khanna, Y Yu, R M Huff, et al.
Journal of Medicinal Chemistry|January 5, 1996
Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipsH C Huang, J J Li, D J Garland, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
Pageof 9